主页文献库搜索
Pathway-specific engineered mouse allograft models functionally recapitulate ...

Szabova(Ludmila),Bupp(Sujata),Kamal(Muhaym... PLoS One 2015-05-29

...Brca2 that develop serous epithelial ovarian cancer (SEOC) closely resembling the human disease on histologic and molecu...

DNA double-strand break repair pathway choice and cancer.

Aparicio(Tomas),Baer(Richard),Gautier(Jean... DNA Repair (Amst) 2015-02-12

...BRCA2 mutations, that disrupt DSB repair are often associated with cancer susceptibility. In addition, recent evidence s...

Use of fertility drugs and risk of ovarian cancer.

Diergaarde(Brenda),Kurta(Michelle L) Curr Opin Obstet Gynecol 2015-01-12

...BRCA2 mutations and borderline ovarian tumours, still remain. In addition, it may currently just be too early to determi...

The validation and clinical implementation of BRCAplus: a comprehensive high-...

Chong(Hansook Kim),Wang(Tao),Lu(Hsiao-Mei)... PLoS One 2015-01-29

...BRCA2 account for a high percentage of hereditary cases, there are more than 25 susceptibility genes that differentially...

BRCA2 coordinates the activities of cell-cycle kinases to promote genome stab...

Yata(Keiko),Bleuyard(Jean-Yves),Nakato(Ryu... Cell Rep 2015-08-21

...BRCA2, a key Rad51 binding partner, coordinates the activity of the central cell-cycle drivers CDKs and Plk1 to promote ...

Unique molecular signatures as a hallmark of patients with metastatic breast ...

Wheler(Jennifer J),Parker(Barbara A),Lee(J... Oncotarget 2015-02-19

...BRCA2, EGFR, IRS2, CDH1, CDKN2A, FGF19, FGF3 and FGF4. Aberrations included mutations (46%), amplifications (45%), delet...

An integrated in silico approach to analyze the involvement of single amino a...

Doss(C George Priya),Nagasundaram(N) Cell Biochem Biophys 2015-07-02

...BRCA2-PALB2, and F1524V, V1532F in FANCD1/BRCA2-RAD51). Analysis of the MD trajectories indicated that predicted deleter...

Germline BRCA mutation evaluation in a prospective triple-negative breast can...

Sharma(Priyanka),Klemp(Jennifer R),Kimler(... Breast Cancer Res Treat 2015-01-12

...BRCA2:4.3 %). SFH reported by 36 % of patients. Mutation prevalence in patients with and without SFH was 31.6 and 6.1 %,...

Utilization of multigene panels in hereditary cancer predisposition testing: ...

LaDuca(Holly),Stuenkel(A J),Dolinsky(Jill ... Genet Med 2015-07-06

...BRCA2 not included), depending on the panel ordered (BreastNext, OvaNext, ColoNext, or CancerNext). Next-generation sequ...

Familial pancreatic cancer: challenging diagnostic approach and therapeutic m...

Mastoraki(Aikaterini),Chatzimavridou-Grigo... J Gastrointest Cancer 2015-03-31

...BRCA2, and hereditary nonpolyposis colorectal cancer (HNPCC) mutation carriers. It was also agreed that initial screenin...

上一页 103 104 105 106 107 108 109 110 111 下一页 107 / 共 632

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com